Article info
Editorial
Soluble vascular endothelial growth factor receptor (VEGFR)-2 in macular oedema—a mechanism for regulating angiogenesis?
- Correspondence to Dr Gregory YH Lip, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Dudley Road, Birmingham B18 7QH, UK; g.y.h.lip{at}bham.ac.uk
Citation
Soluble vascular endothelial growth factor receptor (VEGFR)-2 in macular oedema—a mechanism for regulating angiogenesis?
Publication history
- Accepted January 16, 2011
- First published February 16, 2011.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.